WO2009071776A2 - Antimicrobial composition that can be used in cosmetics and in dermatology - Google Patents

Antimicrobial composition that can be used in cosmetics and in dermatology Download PDF

Info

Publication number
WO2009071776A2
WO2009071776A2 PCT/FR2008/001346 FR2008001346W WO2009071776A2 WO 2009071776 A2 WO2009071776 A2 WO 2009071776A2 FR 2008001346 W FR2008001346 W FR 2008001346W WO 2009071776 A2 WO2009071776 A2 WO 2009071776A2
Authority
WO
WIPO (PCT)
Prior art keywords
composition
acid
composition according
carbon atoms
lipoamino
Prior art date
Application number
PCT/FR2008/001346
Other languages
French (fr)
Other versions
WO2009071776A3 (en
Inventor
Nadine Leconte
Original Assignee
Laboratoire Nuxe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Nuxe filed Critical Laboratoire Nuxe
Priority to EP08857034A priority Critical patent/EP2200432A2/en
Publication of WO2009071776A2 publication Critical patent/WO2009071776A2/en
Publication of WO2009071776A3 publication Critical patent/WO2009071776A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A01N37/20Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46N-acyl derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to compositions that can be used in cosmetics and in dermatology, and more particularly to a composition with a bactericidal effect that can be used as a preservative in these cosmetic and dermatological compositions.
  • the skin comprises superficial layers, namely the epidermis, and deeper layers, the dermis and the hypodermis, and each has specific properties allowing the whole to react and adapt to the conditions of its environment.
  • the epidermis which is composed of three types of cells, namely keratinocytes (90% of epidermal cells), melanocytes (2 to 3% of epidermal cells) and Langerhans cells, constitutes the outer layer and plays a role. fundamental to ensure the protection and maintenance of good trophicity.
  • the dermis serves as a support for the epidermis and consists mainly of fibroblasts and an extracellular matrix essentially based on collagen and elastin.
  • Collagen fibers contribute to the texture and tone of the skin, and elastin is responsible for its elasticity. Other cells, such as macrophages and leucocytes, are also present in the dermis layer.
  • the hypodermis which is the deepest layer of the skin, contains lipid-producing fat cells so that the subcutaneous tissue makes a fat layer that protects muscles, bones, and internal organs from shock.
  • cosmetic and dermatological compositions for the treatment and prevention of skin conditions by topical application must be pleasant to use and must have good physical properties, including consistency and lubricity, while ensuring satisfactory efficiency health and avoiding the disadvantages such as tugging, irritation or itching, that may cause certain active ingredients. They must also have good conservation properties by avoiding or limiting the risks of degradation and microbial contamination.
  • Microbial contamination can occur during manufacturing or packaging (primary contamination), or, most often, during the storage and / or use of the products (secondary contamination), especially when this is done a relatively hot and humid environment, favorable to microbial growth, which is generally the case of cosmetics when the containers containing them have been opened and the users have opened them.
  • This microbial proliferation is manifested in the organoleptic characteristics of cosmetic products and in the health of users. It is accompanied by instability of the product manifested by a change in color, an appearance of unpleasant odor, a transformation of the texture, and these effects not only can impair the effectiveness of the product but can also make it uncomfortable for the user, and even sometimes be harmful, for example because of the risk of infection resulting from microbial growth. It is therefore desirable to protect cosmetic products by incorporating preservatives that prevent or limit bacterial growth to enhance consumer safety.
  • preservatives have been used for itshabu ⁇ years in the field of cosmetic and dermatological compositions, such as benzoic acid or p-hydroxy alkyl benzoates, and in particular the methyl p-hydroxy-benzoate (methylparaben ) and propyl p-hydroxybenzoate (Propylparaben), or alcohols, for example ethyl alcohol, benzyl alcohol and phenoxyethanol, or chlorphenesin or imidazolidinyl urea, alone or in combination. combination.
  • methylparaben methylparaben
  • Propylparaben propyl p-hydroxybenzoate
  • alcohols for example ethyl alcohol, benzyl alcohol and phenoxyethanol, or chlorphenesin or imidazolidinyl urea, alone or in combination. combination.
  • Hinokitiol has also been proposed as an antimicrobial preservative but has the disadvantage of being relatively unstable to light.
  • Lipacid® is a lipoamino acid group palmitoyl used in cosmetics for its soothing properties.
  • Patent FR 2,676,741 describes lipoamino acids of vegetable origin which can be incorporated into various cosmetic compositions.
  • Patent application WO 9809611 discloses lauroyl chain lipoamino acids, and in particular lauroyl glutamate, having soothing properties for the skin.
  • FR 2,765,105 proposes to combine lipoamino acids with zinc gluconate to prepare compositions with antibacterial and anti-inflammatory properties useful in the treatment of acne.
  • Some glycerine derivatives are known for their activity against microorganisms responsible for unpleasant odors and can therefore be used in compo- Deodorant cosmetics, such as those described in US Pat. No. 5,516,510, which describes glycerol mono-alkyl ethers such as glycerol 2-ethyl hexyl ether and glycerin dodecyl ether having activity against gram-negative bacteria. positive.
  • Another composition exhibiting antimicrobial activity and comprising a glycerol alkyl ether and a lipoamino acid is described in EP 747,047.
  • Some fatty acids are used in cosmetic compositions, for example for their antimicrobial properties such as 10-hydroxy-decanoic acid which can be used alone or in combination with another active ingredient such as sebacic acid, as described in the patent.
  • FR 2,851,161 which teaches that such an association is effective for masking unpleasant odors and for treating microorganisms responsible for acne.
  • the work carried out by the Applicant has shown that the combination of certain derivatives of glycerin, lipoamino acids and a hydroxylated fatty acid provides an important antimicrobial effect making it possible to use it effectively in cosmetic and dermatological compositions to replace preservatives. such as parabens and phenoxyethanol.
  • the present invention therefore relates to a new antimicrobial composition having a broad spectrum of activity useful in cosmetics and dermatology.
  • the subject of the invention is also a composition that can be used as a preservative in cosmetic and dermatological compositions.
  • the invention also relates to a composition Cosme ⁇ tick and / or dermatological comprising such bactericidal composition providing effective action against bacterial growth and provides excellent conser- vation without causing adverse effects on the user, such than a reaction of intolerance or allergy.
  • the subject of the invention is the use of such a composition for the preparation of a dermatological composition with improved preservation without requiring the use of standard preservatives.
  • the antimicrobial composition for use in cosmetics and dermatology comprises in combination a lipoamino acid, a hydroxylated fatty acid having from 8 to 12 carbon atoms and a glycerin alkyl ether.
  • the lipoamino acid preferably comprises an alkyl chain of 8 to 18 carbon atoms, and more particularly a capryloyl group, a lauroyl group and a palmitoyl group.
  • the hydroxylated fatty acid may for example be 10-hydroxydecanoic acid.
  • the glycerin alkyl ether is preferably selected from ethyl hexyl glycerin and dodecyl glycerine.
  • alkyl chain diol of 8 to 12 carbon atoms such as 1,10-decane-diol.
  • An advantage of the present invention is that it can be composed from commercially available products and, for example, a lipoamino acid such as Lipacid® (capryloyl glycine) can be chosen in proportions generally ranging from 0.5 to 2. % by weight relative to the total weight of the composition, a glycerin ether such as Sensiva® at 0.2 to 3% by weight, and a hydroxylated fatty acid such as Acnacidiol® at 1 to 5% by weight.
  • a lipoamino acid such as Lipacid® (capryloyl glycine)
  • a glycerin ether such as Sensiva® at 0.2 to 3% by weight
  • a hydroxylated fatty acid such as Acnacidiol® at 1 to 5% by weight.
  • antibacterial and preservative compounds according to the present invention is an effective alternative to the use of conventional preservatives. Not only does it have an antibacterial effect making it possible to use it as a preservative in cosmetic compositions, but it also has a potentiated effect on micro-organisms such as Candida albicans and Aspergillus niger compared to its components used in isolation, without having any effect. undesirable secondary.
  • the studies carried out on the combination according to the present invention have shown that it controls the production of skin sebum with good short-term efficiency and has sebum regulating properties in the longer term. It also has an effective deodorant activity, a moisturizing activity and a good emollient power. It also restores the natural acidity of the skin, promotes the balance of the skin's ecosystem, improves skin conditions such as seborrheic dermatitis responsible for skin irritation and flaking, and is active for treatment acne skin.
  • the combination of active principles according to the present invention is particularly remarkable by the speed of its effectiveness causing eradication of the main strains in a period of less than 48 hours. Its activity is particularly effective on the Escherichia coli, Pseudomonas aeruginas, Staphylococcus aureus and Candida albicans strains in less than 48 hours and on Aspergilus niger in a longer time.
  • the antibacterial combination according to the invention also has the advantage of requiring only limited quantities of each of its components, that is to say amounts which are smaller than those recommended by the manufacturers of these components, which allows an improvement in the cutaneous tolerance of the composition.
  • composition according to the invention may contain various substances and excipients chosen according to their known properties, the final application considered and the envisaged dosage form.
  • hydrating agents emulsifiers, surfactants, thickeners, hydrophilic and lipophilic gelling agents, viscosifying agents, antioxidants, vegetable oils, lipids, texturizing agents, a specific solvent such as a glycol as well as water and various additives to improve the physical properties of the compositions.
  • filters or sunscreens chosen according to the desired degree of protection, as well as perfumes.
  • a complementary preservative such as dehydroacetic acid may also be added.
  • the gelling agents or thickeners may for example be chosen from acrylate copolymers, for example acrylate palmeth acrylate copolymer, or natural gums, for example a xanthan gum.
  • the moisturizing or humectant may be selected from a polyol, sorbitol, maltitol, pentaerythritol, glycerin, propylene glycol, polyethylene glycol, polyacrylates and glyceryl polymethacrylates, glycerol or glycerol derivatives.
  • any moisturizing agent suitable for cosmetic or dermatological compositions may be used in the present invention.
  • emulsifying agents may be used depending on the intended use and may be chosen for example from crosslinked copolymers of the acidic type. acrylic acid / alkyl acrylate (e.g. Carbopol 1342® and Pemulen TRi®), polysorbates (e.g. Tween 20 or Tween ® 60), sorbitan esters. It is also possible to use emulsifying agents such as stearic or palmitic acid derivatives, and for example PEG 100® stearate, stearic or palmitic acid mono- or diglycerides, glycerol stearate, polyethylene stearate, and the like. glycol, a steareth or a ceteart, an emulsifiable silicone. or natural emulsifiers such as glucosides (cetearyl and arachidyl) or hydrogenated lecithins.
  • acrylic acid / alkyl acrylate e.g. Carbopol 1342® and Pe
  • Ultraviolet protection agents may also be incorporated in the compositions, and for example sunscreens such as benzophenone or a benzophenone derivative, a dibenzoylmethane derivative such as 4-isopropyl dibenzoylmethane, or cinnamate and more particularly ethylhexyl methoxycinnamate. It is also possible to use anti-ultraviolet screen pigments, which may for example be chosen from titanium dioxide, zinc oxide or aluminum oxide.
  • the antimicrobial composition of the invention can be incorporated into cosmetic compositions such as moisturizing creams, nourishing creams, wrinkle creams, facial cleansing gels, toning lotions, make-up remover lotions, sunscreen creams, body milks, shampoos, hair products, anti-acne products, shower gels or creams, etc.
  • an anti-wrinkle cream having the following composition is prepared.
  • the combination of the invention consists of Lipacid® (0.5% of the total weight of the composition), ethyl hexyl glycerine (0.3% by weight) and Acnacidiol® (2.5% in weight) .
  • a moisturizing gel having the composition indicated below is prepared.
  • This test consists of the artificial contamination of a preparation by means of an inoculum of microorganisms appropriate and prescribed by the European Pharmacopoeia. This inoculated preparation is kept away from light at 20-25 ° C for the duration of the test.
  • Samples are taken from the inoculated preparation at a given time interval (TO, T48H, T7J, T14J and T28J) in order to enumerate and search the microorganisms present.
  • the preservation properties are consistent if there is a significant decrease in the number of microorganisms in the seeded preparation during the period of the test.
  • the different stages of the test are as follows:
  • strains used are those recommended by the European Pharmacopoeia namely:
  • Escherichia coli (CIP53.126 ATCC 8739) Each of the bacteria is subcultured on agar B and incubated 18 hours at 30-35 ° C. (Staphylococcus, E Coli and Pseudomonas)
  • Candida albicans is subcultured on CT C agar and incubated for 48 hours at 20-25 ° C.
  • the Aspergillus niger is transplanted onto CT C agar and incubated for 7 days at 20-25 ° C. until satisfactory sporulation is obtained.
  • an agar count is performed to quantify the microorganisms present in the product.
  • the matrix used for the test is an oil / water emulsion, very activated and therefore difficult to keep (the goal being to place in the most unfavorable conditions).
  • This emulsion is composed as follows: Raw material% _
  • Fat phase (ester, vegetable oils, consistency factor) 17.0
  • the inoculum corresponds to the amount of bacteria initially seeded before the onset of the action of the combination of the invention or comparison preservatives. It is found that only the combination according to the invention provides satisfactory results in accordance with the criteria of the pharmacopoeia on all strains, including Aspergillus niger.
  • the combination of the invention provides rapid results since the bacteria and yeasts comply with the criteria of pharmacopoeia from 48 hours (except Aspergillus niger, where the results are better at 14 days). This result is particularly interesting in the case of the primary contamination during manufacture of the cosmetic compositions, where it is important to be able to ensure an immediate preservative effect.
  • composition of the invention is particularly useful as a preservative in cosmetic and dermatological compositions.

Abstract

The invention concerns a novel antimicrobial composition. The composition comprises a combination of a lipoamino acid preferably comprising an alkylated chain containing from 8 to 18 carbon atoms, a hydroxylated fatty acid containing from 8 to 12 carbon atoms, such as 10-hydroxydecanoic acid, and an alkyl ether of glycerol such as ethylhexyl glycerol and dodecyl glycerol. Use as a preservative in cosmetic and dermatological compositions.

Description

COMPOSITION ANTIMICROBIENNE UTILISABLE EN COSMETIQUE ET EN DERMATOLOGIE ANTIMICROBIAL COMPOSITION FOR USE IN COSMETICS AND DERMATOLOGY
La présente invention concerne les compositions utilisables en cosmétique et en dermatologie, et plus particulièrement une composition à effet bactéricide utilisable comme conservateur dans ces compositions cosmétiques et dermato- logiques.The present invention relates to compositions that can be used in cosmetics and in dermatology, and more particularly to a composition with a bactericidal effect that can be used as a preservative in these cosmetic and dermatological compositions.
La peau comprend des couches superficielles, à savoir l'épiderme, et des couches plus profondes, le derme et 1' hypoderme, et chacune possède des propriétés spécifiques permettant à l'ensemble de réagir et s'adapter aux conditions de son environnement. L'épiderme, qui est composé de trois types de cellules, à savoir des kératinocytes (90% des cellules épidermiques) , des mélanocytes (2 à 3% des cellules épidermiques) et des cellules de Langerhans, constitue la couche externe et joue un rôle fondamental pour assure.r la protection et le maintien d'une bonne trophicité. Le derme sert de support à l'épiderme et est principalement constitué de fibroblastes et d'une matrice extracellulaire essentiellement à base de collagène et d'élastine. Les fibres de col- lagène contribuent à la texture et à la tonicité de la peau, et l'élastine est responsable de son élasticité. D'autres cellules, comme les macrophages et les leucocytes, sont également présentes dans la couche du derme. L' hypoderme, qui est la couche la plus profonde de la peau, contient les adipocytes qui produisent des lipides pour que le tissu sous- cutané fabrique une couche grasse protégeant les muscles, les os, et les organes internes contre les chocs.The skin comprises superficial layers, namely the epidermis, and deeper layers, the dermis and the hypodermis, and each has specific properties allowing the whole to react and adapt to the conditions of its environment. The epidermis, which is composed of three types of cells, namely keratinocytes (90% of epidermal cells), melanocytes (2 to 3% of epidermal cells) and Langerhans cells, constitutes the outer layer and plays a role. fundamental to ensure the protection and maintenance of good trophicity. The dermis serves as a support for the epidermis and consists mainly of fibroblasts and an extracellular matrix essentially based on collagen and elastin. Collagen fibers contribute to the texture and tone of the skin, and elastin is responsible for its elasticity. Other cells, such as macrophages and leucocytes, are also present in the dermis layer. The hypodermis, which is the deepest layer of the skin, contains lipid-producing fat cells so that the subcutaneous tissue makes a fat layer that protects muscles, bones, and internal organs from shock.
Pour être acceptées par les utilisateurs, les compositions cosmétiques et dermatologiques destinées au traitement et à la prévention des affections de la peau par application topique doivent être agréables à utiliser et doivent présenter de bonnes propriétés physiques, notamment de consistance et d'onctuosité, tout en garantissant une efficacité satisfai- santé et en évitant les inconvénients tels que tiraillements, irritations ou démangeaisons, que peuvent occasionner certains principes actifs. Elles doivent aussi posséder de bonnes propriétés de conservation en évitant ou limitant les risques de dégradation et de contamination microbienne.To be accepted by users, cosmetic and dermatological compositions for the treatment and prevention of skin conditions by topical application must be pleasant to use and must have good physical properties, including consistency and lubricity, while ensuring satisfactory efficiency health and avoiding the disadvantages such as tugging, irritation or itching, that may cause certain active ingredients. They must also have good conservation properties by avoiding or limiting the risks of degradation and microbial contamination.
Les problèmes liés à la contamination microbienne et à l'instabilité qui peut en résulter ont donné lieu à de nombreux travaux de recherche dans le domaine des compositions cosmétiques, pharmaceutiques et alimentaires, afin de mettre au point des substances ou des compositions susceptibles d'empêcher ou de limiter cette contamination. La contamination microbienne peut se produire lors de la fabrication ou du conditionnement (contamination primaire) , ou, le plus souvent, lors de la conservation et/ou de l'utilisation des produits (contamination secondaire) , en particulier lorsque cette conservation se fait dans un environnement relativement chaud et humide, favorable à la prolifération microbienne, ce qui est généralement le cas des produits cosmétiques quand les récipients les contenant ont été ouverts et que les utili- sateurs les ont entamés.The problems associated with microbial contamination and the resulting instability have led to a great deal of research in the field of cosmetic, pharmaceutical and food compositions, in order to develop substances or compositions that may prevent or limit this contamination. Microbial contamination can occur during manufacturing or packaging (primary contamination), or, most often, during the storage and / or use of the products (secondary contamination), especially when this is done a relatively hot and humid environment, favorable to microbial growth, which is generally the case of cosmetics when the containers containing them have been opened and the users have opened them.
Cette prolifération microbienne se manifeste au niveau des caractéristiques organoleptiques des produits cosmétiques et au niveau de la santé des utilisateurs. Elle s'accompagne d'une instabilité du produit se manifestant par une modifi- cation de la couleur, une apparition d'odeur désagréable, une transformation de la texture, et ces effets non seulement peuvent nuire à l'efficacité du produit mais peuvent aussi le rendre peu agréable à l'utilisateur, et même parfois être néfastes, par exemple en raison des risques d'infection résultant de la prolifération microbienne. Il est donc souhaitable de protéger les produits cosmétiques en y incorporant des conservateurs qui empêchent ou limitent la prolifération bactérienne afin de renforcer la sécurité des consommateurs . Divers conservateurs ont été utilisés depuis de nombreu¬ ses années dans le domaine des compositions cosmétiques et dermatologiques, tels que l'acide benzoïque ou un p-hydroxy- benzoate d'alkyle, et en particulier le p-hydroxy-benzoate de méthyle (Méthylparaben) et le p-hydroxy-benzoate de propyle (Propylparaben) , ou des alcools, par exemple l'alcool éthy- lique, l'alcool benzylique et le phénoxy-éthanol, ou encore la chlorphénésine ou 1 ' imidazolidinyl urée, isolément ou en combinaison. L'utilisation de certains de ces conservateurs a cependant été parfois déconseillée car ils seraient susceptibles d'avoir des effets néfastes sur la santé des utilisateurs lorsque leur concentration est trop importante, par exemple en provoquant parfois des réactions d'allergie ou d'intolérance cutanée. L 'hinokitiol a aussi été proposé comme conservateur antimicrobien mais il présente l'inconvénient d'être relativement instable à la lumière.This microbial proliferation is manifested in the organoleptic characteristics of cosmetic products and in the health of users. It is accompanied by instability of the product manifested by a change in color, an appearance of unpleasant odor, a transformation of the texture, and these effects not only can impair the effectiveness of the product but can also make it uncomfortable for the user, and even sometimes be harmful, for example because of the risk of infection resulting from microbial growth. It is therefore desirable to protect cosmetic products by incorporating preservatives that prevent or limit bacterial growth to enhance consumer safety. Various preservatives have been used for its nombreu ¬ years in the field of cosmetic and dermatological compositions, such as benzoic acid or p-hydroxy alkyl benzoates, and in particular the methyl p-hydroxy-benzoate (methylparaben ) and propyl p-hydroxybenzoate (Propylparaben), or alcohols, for example ethyl alcohol, benzyl alcohol and phenoxyethanol, or chlorphenesin or imidazolidinyl urea, alone or in combination. combination. The use of some of these preservatives has, however, sometimes been discouraged because they could have adverse effects on the health of users when their concentration is too high, for example by sometimes causing allergy or cutaneous intolerance reactions. . Hinokitiol has also been proposed as an antimicrobial preservative but has the disadvantage of being relatively unstable to light.
D'autres additifs pour compositions cosmétiques et alimentaires ont été proposés. Ainsi, on connaît diverses substances et compositions présentant des effets utiles dans des compositions cosmétiques pour en faciliter l'application sur la peau, et par exemple le produit Lipacid® est un lipoaminoacide à groupe palmitoyl utilisé en cosmétique pour ses propriétés apaisantes. Le brevet FR 2.676.741 décrit des lipoaminoacides d'origine végétale qui peuvent être incorporés dans diverses compositions cosmétiques. La demande de brevet WO 9809611 décrit des lipoamino-acides à chaîne lauroyle, et en particulier le glutamate de lauroyle, présentant des propriétés apaisantes pour la peau. Le brevet FR 2.765.105 propose d'associer des lipoaminoacides avec du gluconate de zinc pour préparer des compositions à propriétés antibactériennes et anti-inflammatoires utiles dans le traitement de l'acné.Other additives for cosmetic and food compositions have been proposed. Thus, there are known various substances and compositions having effects useful in cosmetic compositions to facilitate application to the skin, and for example the product Lipacid® is a lipoamino acid group palmitoyl used in cosmetics for its soothing properties. Patent FR 2,676,741 describes lipoamino acids of vegetable origin which can be incorporated into various cosmetic compositions. Patent application WO 9809611 discloses lauroyl chain lipoamino acids, and in particular lauroyl glutamate, having soothing properties for the skin. FR 2,765,105 proposes to combine lipoamino acids with zinc gluconate to prepare compositions with antibacterial and anti-inflammatory properties useful in the treatment of acne.
Certains dérivés de glycérine sont connus pour leur activité contre des micro-organismes responsables d'odeurs désagréables et peuvent donc être utilisés dans des compo- sitions cosmétiques désodorisantes, comme par exemple celles décrites dans le brevet US 5.516.510 qui décrit des mono-alkyl éthers de glycérine tels que le 2-éthyl-hexyl éther de glycérine et le dodécyl éther de glycérine possédant une activité contre les bactéries gram-positives . Une autre composition présentant une activité antimicrobienne et comprenant un alkyléther de glycérol et un lipoaminoacide est décrite dans EP 747.047.Some glycerine derivatives are known for their activity against microorganisms responsible for unpleasant odors and can therefore be used in compo- Deodorant cosmetics, such as those described in US Pat. No. 5,516,510, which describes glycerol mono-alkyl ethers such as glycerol 2-ethyl hexyl ether and glycerin dodecyl ether having activity against gram-negative bacteria. positive. Another composition exhibiting antimicrobial activity and comprising a glycerol alkyl ether and a lipoamino acid is described in EP 747,047.
Certains acides gras sont utilisés dans des compositions cosmétiques, par exemple pour leurs propriétés antimicrobiennes comme l'acide 10-hydroxy-décanoïque qui peut être utilisé isolément ou en association avec un autre principe actif tel que l'acide sébacique, comme décrit dans le brevet FR 2.851.161, qui enseigne qu'une telle association est efficace pour masquer les mauvaises odeurs et pour traiter les micro-organismes responsables de l'acné.Some fatty acids are used in cosmetic compositions, for example for their antimicrobial properties such as 10-hydroxy-decanoic acid which can be used alone or in combination with another active ingredient such as sebacic acid, as described in the patent. FR 2,851,161, which teaches that such an association is effective for masking unpleasant odors and for treating microorganisms responsible for acne.
La mise au point de nouveaux produits ou de nouvelles compositions pour assurer dans de bonnes conditions la conservation des produits cosmétiques est aujourd'hui encore ressentie comme une nécessité afin de trouver des alternatives aux produits existants tels que les parabens et le phénoxy- éthanol .The development of new products or new compositions to ensure the conservation of cosmetic products under good conditions is still felt today as a necessity in order to find alternatives to existing products such as parabens and phenoxyethanol.
Les travaux effectués par la demanderesse ont montré que l'association de certains dérivés de glycérine, de lipoamino- acides et d'un acide gras hydroxylé procurait un important effet antimicrobien permettant de l'utiliser efficacement dans des compositions cosmétiques et dermatologiques en remplacement des conservateurs traditionnels tels que les parabens et le phénoxyéthanol . La présente invention a donc pour objet une nouvelle composition à effet antimicrobien présentant un large spectre d'activité utile en cosmétique et en dermatologie.The work carried out by the Applicant has shown that the combination of certain derivatives of glycerin, lipoamino acids and a hydroxylated fatty acid provides an important antimicrobial effect making it possible to use it effectively in cosmetic and dermatological compositions to replace preservatives. such as parabens and phenoxyethanol. The present invention therefore relates to a new antimicrobial composition having a broad spectrum of activity useful in cosmetics and dermatology.
L'invention a aussi pour objet une composition utilisable comme conservateur dans des compositions cosmétiques et dermatologiques. L'invention a encore pour objet une composition cosmé¬ tique et/ou dermatologique comprenant une telle composition à effet bactéricide procurant une action efficace contre la prolifération bactérienne et assurant une excellente conser- vation sans engendrer d'effet indésirable sur l'utilisateur, tel qu'une réaction d'intolérance ou d'allergie.The subject of the invention is also a composition that can be used as a preservative in cosmetic and dermatological compositions. The invention also relates to a composition Cosme ¬ tick and / or dermatological comprising such bactericidal composition providing effective action against bacterial growth and provides excellent conser- vation without causing adverse effects on the user, such than a reaction of intolerance or allergy.
Enfin, l'invention a pour objet l'utilisation d'une telle composition pour la préparation d'une composition dermatologique à conservation améliorée sans requérir l'utilisation de conservateurs standard.Finally, the subject of the invention is the use of such a composition for the preparation of a dermatological composition with improved preservation without requiring the use of standard preservatives.
La composition antimicrobienne utilisable en cosmétique et en dermatologie suivant la présente invention comprend en combinaison un lipoaminoacide, un acide gras hydroxylé comportant de 8 à 12 atomes de carbone et un alkyléther de glycérine.The antimicrobial composition for use in cosmetics and dermatology according to the present invention comprises in combination a lipoamino acid, a hydroxylated fatty acid having from 8 to 12 carbon atoms and a glycerin alkyl ether.
Dans la composition suivant la présente invention, le lipoaminoacide comporte de préférence une chaîne alkylée de 8 à 18 atomes de carbone, et plus particulièrement un groupe capryloyle, un groupe lauroyle et un groupe palmitoyle. L'acide gras hydroxylé peut être par exemple l'acide 10- hydroxydécanoïque .In the composition according to the present invention, the lipoamino acid preferably comprises an alkyl chain of 8 to 18 carbon atoms, and more particularly a capryloyl group, a lauroyl group and a palmitoyl group. The hydroxylated fatty acid may for example be 10-hydroxydecanoic acid.
L'alkyl éther de glycérine est de préférence choisi parmi 1 ' éthyl hexyl glycérine et la dodécyl glycérine.The glycerin alkyl ether is preferably selected from ethyl hexyl glycerin and dodecyl glycerine.
Il peut être utile d'ajouter à la composition un diol à chaîne alkylée de 8 à 12 atomes de carbone tel que le 1,10- décane-diol .It may be useful to add to the composition an alkyl chain diol of 8 to 12 carbon atoms such as 1,10-decane-diol.
Les essais effectués ont montré que l'efficacité de la composition de l'invention est encore améliorée par addition d'acide sébacique et/ou de butylène glycol . Un avantage de la présente invention est qu'elle peut être composée à partir de produits disponibles dans le commerce et par exemple, on peut choisir un lipoaminoacide tel que le Lipacid® (capryloyl glycine) dans des proportions comprises généralement entre 0,5 et 2% en poids par rapport au poids total de la composition, un éther de glycérine tel que le Sensiva® à raison de 0,2 à 3% en poids, et un acide gras hydroxylé tel que 1 ' Acnacidiol® à raison de 1 à 5% en poids. Ces produits utilisables dans la composition de l'invention sont adaptés à l'utilisation en cosmétique en raison de leur bonne innocuité .The tests carried out have shown that the effectiveness of the composition of the invention is further improved by the addition of sebacic acid and / or butylene glycol. An advantage of the present invention is that it can be composed from commercially available products and, for example, a lipoamino acid such as Lipacid® (capryloyl glycine) can be chosen in proportions generally ranging from 0.5 to 2. % by weight relative to the total weight of the composition, a glycerin ether such as Sensiva® at 0.2 to 3% by weight, and a hydroxylated fatty acid such as Acnacidiol® at 1 to 5% by weight. These products that can be used in the composition of the invention are suitable for use in cosmetics because of their good safety.
L'association de composés à effet antibactérien et conservateur suivant la présente invention constitue une alternative efficace à l'utilisation des conservateurs classiques . Non seulement elle présente un effet antibactérien permettant de l'utiliser comme conservateur dans des compositions cosmétiques, mais elle procure un effet potentialisé sur des micro-organismes tels que Candida albicans et Aspergillus niger par comparaison avec ses composants utilisés isolément, sans entraîner d'effet secondaire indésirable.The combination of antibacterial and preservative compounds according to the present invention is an effective alternative to the use of conventional preservatives. Not only does it have an antibacterial effect making it possible to use it as a preservative in cosmetic compositions, but it also has a potentiated effect on micro-organisms such as Candida albicans and Aspergillus niger compared to its components used in isolation, without having any effect. undesirable secondary.
Les études effectuées sur l'association suivant la présente invention ont montré qu'elle contrôle la production de sébum de la peau avec une bonne efficacité à court terme et présente des propriétés séborégulatrice à plus long terme. Elle possède aussi une activité désodorisante efficace, une activité hydratante et un bon pouvoir émollient. Elle permet aussi de restaurer l'acidité naturelle de la peau, favorise l'équilibre de l'écosystème cutané, améliore les états cutanés tels que les dermites séborrhéiques responsables d'irritations de la peau et de desquamations, et se montre active pour le traitement des peaux acnéiques.The studies carried out on the combination according to the present invention have shown that it controls the production of skin sebum with good short-term efficiency and has sebum regulating properties in the longer term. It also has an effective deodorant activity, a moisturizing activity and a good emollient power. It also restores the natural acidity of the skin, promotes the balance of the skin's ecosystem, improves skin conditions such as seborrheic dermatitis responsible for skin irritation and flaking, and is active for treatment acne skin.
L'association de principes actifs conforme à la présente invention est particulièrement remarquable par la rapidité de son efficacité provoquant une éradication des principales souches dans un délai de moins de 48 heures. Son activité est tout particulièrement efficace sur les souches Escherichia coli, Pseudomonas aeruginas, Staphylococcus aureus et Candida albicans dans un délai inférieur à 48 heures et sur Aspergilus niger dans un délai supérieur. L'association antibactérienne suivant l'invention présente en outre l'avantage de ne nécessiter que des quantités limitées de chacun de ses composants, c'est-à-dire des quantités inférieures à celles préconisées par les fabricants de ces composants, ce qui permet une amélioration de la tolérance cutanée de la composition.The combination of active principles according to the present invention is particularly remarkable by the speed of its effectiveness causing eradication of the main strains in a period of less than 48 hours. Its activity is particularly effective on the Escherichia coli, Pseudomonas aeruginas, Staphylococcus aureus and Candida albicans strains in less than 48 hours and on Aspergilus niger in a longer time. The antibacterial combination according to the invention also has the advantage of requiring only limited quantities of each of its components, that is to say amounts which are smaller than those recommended by the manufacturers of these components, which allows an improvement in the cutaneous tolerance of the composition.
Outre l'association antibactérienne ci-dessus, la composition suivant l'invention peut contenir diverses substances et excipients choisis en fonction de leurs propriétés connues, de l'application finale considérée et de la forme galénique envisagée. Ainsi, on peut incorporer des agents hydratants, des agents émulsionnants, des tensioactifs, des épaississants, des gélifiants hydrophiles et lipophiles, des agents visco- sants, des antioxydants, des huiles végétales, des lipides, des agents de texture, un solvant spécifique tel qu'un glycol ainsi que de l'eau et divers additifs destinés à améliorer les propriétés physiques des compositions . On peut encore avantageusement incorporer des filtres ou écrans solaires choisis en fonction du degré de protection recherché, ainsi que des parfums . Le cas échéant un conservateur complémentaire tel que l'acide déhydroacétique peut aussi être ajouté.In addition to the above antibacterial combination, the composition according to the invention may contain various substances and excipients chosen according to their known properties, the final application considered and the envisaged dosage form. Thus, hydrating agents, emulsifiers, surfactants, thickeners, hydrophilic and lipophilic gelling agents, viscosifying agents, antioxidants, vegetable oils, lipids, texturizing agents, a specific solvent such as a glycol as well as water and various additives to improve the physical properties of the compositions. It is also advantageous to incorporate filters or sunscreens chosen according to the desired degree of protection, as well as perfumes. If necessary, a complementary preservative such as dehydroacetic acid may also be added.
Les gélifiants ou épaississants peuvent par exemple être choisis parmi les copolymères d'acrylate, par exemple l'acrylate palmeth 25 acrylate copolymer, ou des gommes naturelles, par exemple une gomme de xanthane .The gelling agents or thickeners may for example be chosen from acrylate copolymers, for example acrylate palmeth acrylate copolymer, or natural gums, for example a xanthan gum.
L'agent hydratant ou humectant peut être choisi parmi un polyol, le sorbitol, le maltitol, le pentaérythritol, la glycérine, le propylène glycol, le polyéthylène glycol, les polyacrylates et polyméthacrylates de glycéryle, le glycérol ou des dérivés du glycérol. D'une manière générale, tout agent hydratant convenant aux compositions cosmétiques ou dermatologiques peut être utilisé dans la présente invention.The moisturizing or humectant may be selected from a polyol, sorbitol, maltitol, pentaerythritol, glycerin, propylene glycol, polyethylene glycol, polyacrylates and glyceryl polymethacrylates, glycerol or glycerol derivatives. In general, any moisturizing agent suitable for cosmetic or dermatological compositions may be used in the present invention.
Divers agents émulsionnants peuvent être utilisés en fonction de l'utilisation envisagée et peuvent être choisis par exemple parmi des copolymères réticulés du type acide acrylique / acrylate d'alkyle (par exemple Carbopol 1342® et Pemulen TRI®) , des polysorbates (par exemple le Tween 20 ou le Tween 60®), des esters de sorbitane. On peut aussi utiliser des agents émulsionnants tels que des dérivés d'acide stéarique ou palmitique, et par exemple le stéarate de PEG 100®, des mono- ou diglycérides d'acide stéarique ou palmitique, le stéarate de glycérol, un stéarate de polyéthy- lène glycol, un stéareth ou un cétéareth, une silicone émul- sionnable. ou encore des émulsionnants naturels tels que des glucosides (cetearyl et arachidyl) ou lécithines hydrogénées.Various emulsifying agents may be used depending on the intended use and may be chosen for example from crosslinked copolymers of the acidic type. acrylic acid / alkyl acrylate (e.g. Carbopol 1342® and Pemulen TRi®), polysorbates (e.g. Tween 20 or Tween ® 60), sorbitan esters. It is also possible to use emulsifying agents such as stearic or palmitic acid derivatives, and for example PEG 100® stearate, stearic or palmitic acid mono- or diglycerides, glycerol stearate, polyethylene stearate, and the like. glycol, a steareth or a ceteart, an emulsifiable silicone. or natural emulsifiers such as glucosides (cetearyl and arachidyl) or hydrogenated lecithins.
Des agents de protection contre les rayons ultraviolets peuvent également être incorporés dans les compositions, et par exemple des filtres solaires tels que la benzophénone ou un dérivé de benzophénone, un dérivé du dibenzoylméthane tel que le 4-isopropyl dibenzoylméthane, ou un cinnamate et plus particulièrement le méthoxycinnamate d ' éthylhexyle . On peut aussi utiliser des pigments formant écran anti-ultraviolet, qui peuvent par exemple être choisis parmi le dioxyde de titane, l'oxyde de zinc ou d'aluminium. Ainsi, la composition antimicrobienne de l'invention peut être incorporée dans des compositions cosmétiques telles que des crèmes hydratantes, des crèmes nourrissantes, des crèmes antirides, des gels nettoyant pour le visage, des lotions tonifiantes, des lotions démaquillantes, des crèmes solaires, des laits pour le corps, des shampooings, des produits capillaires, des produits anti-acnéiques, des gels ou crèmes de douches, etc.Ultraviolet protection agents may also be incorporated in the compositions, and for example sunscreens such as benzophenone or a benzophenone derivative, a dibenzoylmethane derivative such as 4-isopropyl dibenzoylmethane, or cinnamate and more particularly ethylhexyl methoxycinnamate. It is also possible to use anti-ultraviolet screen pigments, which may for example be chosen from titanium dioxide, zinc oxide or aluminum oxide. Thus, the antimicrobial composition of the invention can be incorporated into cosmetic compositions such as moisturizing creams, nourishing creams, wrinkle creams, facial cleansing gels, toning lotions, make-up remover lotions, sunscreen creams, body milks, shampoos, hair products, anti-acne products, shower gels or creams, etc.
Les caractéristiques et avantages de la présente invention apparaîtront plus en détail dans la description qui suit, relative à des formes préférentielles de réalisation. Dans ces exemples, les parties et pourcentages sont exprimés en poids, sauf indication contraire. Exemple 1The features and advantages of the present invention will appear in more detail in the description which follows, relating to preferred embodiments. In these examples, parts and percentages are by weight unless otherwise indicated. Example 1
Par les techniques classiques, on prépare une crème antirides ayant la composition suivante.By conventional techniques, an anti-wrinkle cream having the following composition is prepared.
Eau qsp 100,0 Parfum 0.8Water qs 100.0 Scent 0.8
Glycérine 5,0Glycerin 5.0
Tromethamine 0,6Tromethamine 0.6
Association de l'invention 3,3 carbomer 0,3 émulsionnant 5,0 esters, huiles végétales 17,0 actifs divers 17,0 poudre 1,5Invention Association 3.3 carbomer 0.3 emulsifier 5.0 esters, vegetable oils 17.0 various actives 17.0 powder 1.5
L'association de l'invention est constituée par du Lipacid® (0,5% du poids total de la composition), de 1 ' éthyl hexyl glycérine (0,3% en poids) et d' Acnacidiol® (2,5% en poids) .The combination of the invention consists of Lipacid® (0.5% of the total weight of the composition), ethyl hexyl glycerine (0.3% by weight) and Acnacidiol® (2.5% in weight) .
Exemple 2Example 2
On prépare un gel hydratant ayant la composition indiquée ci-après .A moisturizing gel having the composition indicated below is prepared.
Eau qspWater qs
Parfum 0,8Perfume 0.8
Carbomer 0,3Carbomer 0.3
Tromethamine 0,4 Glycols 5,0Tromethamine 0.4 Glycols 5.0
Glycérine 4,0Glycerin 4.0
Association de l'invention 3,3Invention Association 3,3
Actif hydratant 10,0Moisturizing active 10.0
L'association de l'invention est identique à celle utilisée dans l'Exemple 1.The combination of the invention is identical to that used in Example 1.
Exemple 3Example 3
L'efficacité de l'association suivant l'invention a été vérifiée par les essais décrits ci-après. Principe global du test :The effectiveness of the combination according to the invention was verified by the tests described below. Overall principle of the test:
Cet essai consiste en la contamination artificielle d'une préparation au moyen d'un inoculum de microorganismes appropriés et prescrits par la Pharmacopée Européenne. Cette préparation inoculée est maintenue à l'abri de la lumière entre 20 et 25°C pendant la durée de l'essai.This test consists of the artificial contamination of a preparation by means of an inoculum of microorganisms appropriate and prescribed by the European Pharmacopoeia. This inoculated preparation is kept away from light at 20-25 ° C for the duration of the test.
Des prélèvements d' échantillons sont réalisés à partir de la préparation inoculée à intervalle de temps donné (TO, T48H, T7J, T14J et T28J) afin de dénombrer et rechercher les micro- organismes présents .Samples are taken from the inoculated preparation at a given time interval (TO, T48H, T7J, T14J and T28J) in order to enumerate and search the microorganisms present.
Les propriétés de conservation sont conformes si on assiste à une diminution importante du nombre de microorganismes dans la préparation ensemencée durant la période de 1' essai . Les différentes étapes du test sont les suivantes :The preservation properties are consistent if there is a significant decrease in the number of microorganisms in the seeded preparation during the period of the test. The different stages of the test are as follows:
Préparation des souchesPreparation of strains
Les quatre souches utilisées sont celles recommandées par la Pharmacopée Européenne à savoir :The four strains used are those recommended by the European Pharmacopoeia namely:
- Pseudomonas aeruginosa (CIP82.118 ATCC 9027) - Staphylococcus aureus (CIP 4.83 ATCC 6538)- Pseudomonas aeruginosa (CIP82.118 ATCC 9027) - Staphylococcus aureus (CIP 4.83 ATCC 6538)
- Candida albicans (IP 48.72 (ATCC 10231)- Candida albicans (IP 48.72 (ATCC 10231)
- Aspergillus niger (IP 1431.83 ATCC 16404) et une souche supplémentaire (entérobactérie) :- Aspergillus niger (IP 1431.83 ATCC 16404) and an additional strain (Enterobacterium):
- Escherichia coli (CIP53.126 ATCC 8739) Chacune des bactéries est repiquée sur gélose B et incubée 18 à 24h à 30-350C (Staphylocoque, E Coli et pseudomonas)Escherichia coli (CIP53.126 ATCC 8739) Each of the bacteria is subcultured on agar B and incubated 18 hours at 30-35 ° C. (Staphylococcus, E Coli and Pseudomonas)
Le Candida albicans est repiqué sur gélose C CT et incubé 48h à 20-250C L'Aspergillus niger est repiqué sur gélose C CT et incubé 7 jours à 20-250C jusqu'à l'obtention d'une sporulation satisfaisante.Candida albicans is subcultured on CT C agar and incubated for 48 hours at 20-25 ° C. The Aspergillus niger is transplanted onto CT C agar and incubated for 7 days at 20-25 ° C. until satisfactory sporulation is obtained.
Des suspensions de germes titrant entre 107 et 108 UFC/ml sont préparées dans les diluants appropriés Ces souches sont ensuite contrôlées et dénombrées avant d'effectuer les essais avec l'association de l'invention.Suspensions of germs measuring between 10 7 and 10 8 CFU / ml are prepared in the appropriate diluents These strains are then checked and enumerated before carrying out the tests with the combination of the invention.
Réalisation des essais (inoculation des souches)Realization of the tests (inoculation of the strains)
100 μl de chaque suspension de germes titrant 107 et 108 UFC/ml sont ajoutés au produit dilué ; on homogénéise et on incube les différents piluliers à l'abri de la lumière à température du laboratoire (20-250C) pendant toute la durée de l'étude (28 jours) .100 μl of each suspension of germs measuring 10 7 and 10 8 CFU / ml are added to the diluted product; the various pillboxes are homogenized and incubated in the dark at laboratory temperature (20-25 ° C.) throughout the duration of the study (28 days).
Dénombrement A chaque temps de mesure, un dénombrement sur gélose est effectué afin de quantifier les microorganismes présents dans le produit.Enumeration At each measurement time, an agar count is performed to quantify the microorganisms present in the product.
Le résultat en nombres de germes est ensuite calculé en logarithme de base 10.The result in numbers of seeds is then calculated in logarithm of base 10.
Matrice de base utilisée pour le testBase matrix used for the test
La matrice utilisée pour le test est une émulsion huile /eau, très activée et de ce fait difficile à conserver (le but étant de se placer dans les conditions les plus défavorables) . Cette émulsion est composée de la façon suivante : Matière première %_The matrix used for the test is an oil / water emulsion, very activated and therefore difficult to keep (the goal being to place in the most unfavorable conditions). This emulsion is composed as follows: Raw material% _
Eau qspWater qs
Glycérine 5,0 carbomer 0,3Glycerin 5.0 carbomer 0.3
Autre gélifiant 1,3 tromethamine 0,6Other gelling agent 1,3 tromethamine 0.6
Phase grasse (ester, huiles végétales, facteur de consistance) 17,0Fat phase (ester, vegetable oils, consistency factor) 17.0
Tribehenin PEG 20 esters 5,0Tribehenin PEG 20 esters 5.0
Actifs (anti-rides, hydratant) 17,0 Poudre (nitrure de bore) 1,5Active (anti-wrinkle, moisturizing) 17.0 Powder (boron nitride) 1.5
Parfum 0,8Perfume 0.8
Les différents essais testés sont les suivants : Essai 1The different tests tested are as follows: Trial 1
(tableau 1) Matrice + éthylhexylglycérine 0,3% + capryloyl glycine 0,5% + mélange (butylène glycol, acide sébacique, décanediol, acide hydroxydéca- noïque) 2,5%(Table 1) Matrix + ethylhexylglycerin 0.3% + capryloyl glycine 0.5% + mixture (butylene glycol, sebacic acid, decanediol, hydroxydecanic acid) 2.5%
Tableau 1Table 1
Figure imgf000013_0001
Figure imgf000013_0001
Essai 2Trial 2
(tableau 2) Matrice + capryloyl glycine 0,5%(Table 2) Matrix + capryloyl glycine 0.5%
Tableau 2Table 2
Figure imgf000013_0002
Essai 3
Figure imgf000013_0002
Trial 3
(tableau 3) Matrice + éthylhexylglycérine 0,3%(Table 3) Matrix + Ethylhexylglycerin 0.3%
Tableau 3Table 3
Figure imgf000014_0001
Essai 4
Figure imgf000014_0001
Trial 4
(tableau 4; Matrice + mélange (butylène glycol, acide sébacique, décanediol, acide hydroxy- décanoïque) 2,5%(Table 4: Matrix + mixture (butylene glycol, sebacic acid, decanediol, hydroxy decanoic acid) 2.5%
Tableau 4Table 4
Figure imgf000014_0002
Dans les tableaux ci-dessus, l'inoculum correspond à la quantité de bactéries initialement ensemencées avant le début de l'action de l'association de l'invention ou des conservateurs de comparaison. On constate que seule l'association suivant l'invention procure des résultats satisfaisants conformes aux critères de la pharmacopée sur toutes les souches, y compris Aspergillus niger .
Figure imgf000014_0002
In the above tables, the inoculum corresponds to the amount of bacteria initially seeded before the onset of the action of the combination of the invention or comparison preservatives. It is found that only the combination according to the invention provides satisfactory results in accordance with the criteria of the pharmacopoeia on all strains, including Aspergillus niger.
De plus, on constate que l'association de l'invention procure des résultats rapides puisque les bactéries et levures sont conformes aux critères de la pharmacopée dès 48 heures (hormis Aspergillus niger, où les résultats sont meilleurs à 14 jours) . Ce résultat est tout particulièrement intéressant dans le cas de la contamination primaire en cours de fabrication des compositions cosmétiques, où il est important de pouvoir assurer un effet conservateur immédiat.In addition, it is found that the combination of the invention provides rapid results since the bacteria and yeasts comply with the criteria of pharmacopoeia from 48 hours (except Aspergillus niger, where the results are better at 14 days). This result is particularly interesting in the case of the primary contamination during manufacture of the cosmetic compositions, where it is important to be able to ensure an immediate preservative effect.
Ces résultats confirment que la composition de l'invention est particulièrement utile en tant que conservateur dans des compositions cosmétiques et dermatologiques. These results confirm that the composition of the invention is particularly useful as a preservative in cosmetic and dermatological compositions.

Claims

REVENDICATIONS
1. Composition antimicrobienne utilisable en cosmétique et en dermatologie caractérisée en ce qu'elle comprend en combinaison un lipoaminoacide, un acide gras hydroxylé comportant de 8 à 12 atomes de carbone et un alkyléther de glycérine.1. An antimicrobial composition for use in cosmetics and dermatology characterized in that it comprises in combination a lipoamino acid, a hydroxylated fatty acid having from 8 to 12 carbon atoms and a glycerin alkyl ether.
2. Composition selon la revendication 1, caractérisée en ce que le lipoaminoacide comporte une chaîne alkylée de 8 à 18 atomes de carbone.2. Composition according to claim 1, characterized in that the lipoamino acid has an alkyl chain of 8 to 18 carbon atoms.
3. Composition selon la revendication 2, caractérisée en ce que le lipoaminoacide comporte un groupe capryloyle, un groupe lauroyle ou un groupe palmitoyle.3. Composition according to claim 2, characterized in that the lipoamino acid comprises a capryloyl group, a lauroyl group or a palmitoyl group.
4. Composition selon la revendication 1, caractérisée en ce que l'acide gras hydroxylé est l'acide 10-hydroxy- décanoïque . 4. Composition according to claim 1, characterized in that the hydroxylated fatty acid is 10-hydroxy-decanoic acid.
5. Composition selon la revendication 1, caractérisée en ce que l'alkyl éther de glycérine est choisi parmi 1 ' éthyl hexyl glycérine et la dodécyl glycérine.5. Composition according to claim 1, characterized in that the alkyl ether of glycerine is selected from 1 ethyl hexyl glycerin and dodecyl glycerine.
6. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce qu'elle comprend entre 0,5 et 2% en poids, par rapport au poids total de la composition, de lipoaminoacide, de 0,2 à 3% en poids d' éther de glycérine, et de 1 à 5% en poids d'acide gras hydroxylé.6. Composition according to any one of the preceding claims, characterized in that it comprises between 0.5 and 2% by weight, relative to the total weight of the composition, of lipoamino acid, from 0.2 to 3% by weight. of glycerine ether, and from 1 to 5% by weight of hydroxylated fatty acid.
7. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce qu'elle comprend en outre un diol à chaîne alkylée de 8 à 12 atomes de carbone.7. Composition according to any one of the preceding claims, characterized in that it further comprises an alkyl chain diol of 8 to 12 carbon atoms.
8. Compositions selon la revendication 7, caractérisée en ce que le diol est le 1, 10-décane-diol .8. Compositions according to claim 7, characterized in that the diol is 1, 10-decane-diol.
9. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce qu'elle comprend en outre de l'acide sébacique et/ou du butylène glycol .9. Composition according to any one of the preceding claims, characterized in that it further comprises sebacic acid and / or butylene glycol.
10. Composition cosmétique et/ou dermatologique caractérisée en ce qu'elle contient un conservateur constitué par une compositions selon l'une quelconque des revendications précédentes .10. Cosmetic and / or dermatological composition characterized in that it contains a preservative constituted by a compositions according to any one of the preceding claims.
11. Utilisation d'une composition selon l'une quelconque des revendications 1 à 9 pour la préparation d'une composition dermatologique à conservation améliorée. 11. Use of a composition according to any one of claims 1 to 9 for the preparation of a dermatological composition with improved preservation.
PCT/FR2008/001346 2007-09-28 2008-09-26 Antimicrobial composition that can be used in cosmetics and in dermatology WO2009071776A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08857034A EP2200432A2 (en) 2007-09-28 2008-09-26 Antimicrobial composition that can be used in cosmetics and in dermatology

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0706835A FR2921558B1 (en) 2007-09-28 2007-09-28 ANTIMICROBIAL COMPOSITION FOR USE IN COSMETICS AND DERMATOLOGY.
FR0706835 2007-09-28

Publications (2)

Publication Number Publication Date
WO2009071776A2 true WO2009071776A2 (en) 2009-06-11
WO2009071776A3 WO2009071776A3 (en) 2009-08-20

Family

ID=39322519

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/001346 WO2009071776A2 (en) 2007-09-28 2008-09-26 Antimicrobial composition that can be used in cosmetics and in dermatology

Country Status (3)

Country Link
EP (1) EP2200432A2 (en)
FR (1) FR2921558B1 (en)
WO (1) WO2009071776A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012007391A1 (en) * 2010-07-12 2012-01-19 Unilever Plc Preservative system and composition based on glycinate and hydroxyethyl sulfonate salt combination
WO2012007412A1 (en) * 2010-07-12 2012-01-19 Unilever Plc Preservative system and composition based on glycinate and dihydroxypropyl quaternary ammonium salt combination
US8501808B2 (en) 2010-07-12 2013-08-06 Conopco, Inc. Foam enhancement of fatty acyl glycinate surfactants

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676741A1 (en) * 1991-05-22 1992-11-27 Morelle Jean LIPOPOLYAMINOACIDS AND PLANT LIPOPEPTIDES.
US5516510A (en) * 1992-11-26 1996-05-14 Reckitt & Colman Inc. Deodorizing active ingredients
EP0747047A1 (en) * 1995-05-17 1996-12-11 LA ROCHE POSAY Laboratoire Pharmaceutique Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent
FR2765105A1 (en) * 1997-06-25 1998-12-31 Seppic Sa Cosmetic composition for e.g treating acne or hydrating skin and scalp
WO2001093825A1 (en) * 2000-06-09 2001-12-13 Air Liquide Sante (International) Storage-stable compositions of glycerol monoalkyl ethers
FR2851161A1 (en) * 2003-02-19 2004-08-20 Vincience Use of antimicrobial mixture comprising sebacic acid, 10-hydroxydecanoic acid and 1,10-decanediol for treating skin and hair

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676741A1 (en) * 1991-05-22 1992-11-27 Morelle Jean LIPOPOLYAMINOACIDS AND PLANT LIPOPEPTIDES.
US5516510A (en) * 1992-11-26 1996-05-14 Reckitt & Colman Inc. Deodorizing active ingredients
EP0747047A1 (en) * 1995-05-17 1996-12-11 LA ROCHE POSAY Laboratoire Pharmaceutique Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent
FR2765105A1 (en) * 1997-06-25 1998-12-31 Seppic Sa Cosmetic composition for e.g treating acne or hydrating skin and scalp
WO2001093825A1 (en) * 2000-06-09 2001-12-13 Air Liquide Sante (International) Storage-stable compositions of glycerol monoalkyl ethers
FR2851161A1 (en) * 2003-02-19 2004-08-20 Vincience Use of antimicrobial mixture comprising sebacic acid, 10-hydroxydecanoic acid and 1,10-decanediol for treating skin and hair

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012007391A1 (en) * 2010-07-12 2012-01-19 Unilever Plc Preservative system and composition based on glycinate and hydroxyethyl sulfonate salt combination
WO2012007412A1 (en) * 2010-07-12 2012-01-19 Unilever Plc Preservative system and composition based on glycinate and dihydroxypropyl quaternary ammonium salt combination
US8470883B2 (en) 2010-07-12 2013-06-25 Conopco, Inc. Preservative system and composition based on glycinate and hydroxyethyl sulfonate salt combination
US8501808B2 (en) 2010-07-12 2013-08-06 Conopco, Inc. Foam enhancement of fatty acyl glycinate surfactants

Also Published As

Publication number Publication date
WO2009071776A3 (en) 2009-08-20
FR2921558B1 (en) 2009-11-20
FR2921558A1 (en) 2009-04-03
EP2200432A2 (en) 2010-06-30

Similar Documents

Publication Publication Date Title
EP1837013B1 (en) Composition comprising hydroxyapatite and a calcium salt for reinforcing the barrier function of the skin and/or semi-mucus membranes.
EP2691074A1 (en) Composition based on camellia japonica and polygonum hydropiper for protecting the skin
EP0953345A1 (en) Use of at least a hydroxystilbene as an agent for decreasing micro-organism adhesion
FR3112953A1 (en) Cosmetic use of the sacran
EP3684477B1 (en) Cosmetic compositions for treating oily skins
FR2998478A1 (en) Cosmetic use of a mixture of essential oils of lemon catnip, Citronella, clove, lemongrass, Melissa officinalis, green oregano, rosemary, mountain savory and thyme, as desquamating agent and for treating ichthyosis and atopic dermatitis
WO2009071776A2 (en) Antimicrobial composition that can be used in cosmetics and in dermatology
FR3005408A1 (en) USE OF PETROSELINIC ACID TO COMBAT THE AESTHETIC DISORDERS OF SILHOUETTE ASSOCIATED WITH MODIFICATIONS OF ADIPOSE TISSUE
WO2015118281A1 (en) Composition for controlling hair loss
FR2929121A1 (en) Care and/or cleaning of healthy skin of diabetic patients, preferably foot, comprises topical application of composition comprising non bactericide S. aureus anti-adhesive agent, on the skin
EP2811978B1 (en) Use of an apple tree bark extract in a cosmetic anti-ageing composition
EP2811977B1 (en) Use of an apple tree leaf extract in a cosmetic skin-firming composition
FR2960436A1 (en) Use of an essential oil of cedar in an anti-aging cosmetic composition, which is useful for strengthening the barrier function, for the cohesion of skin cells, for the regulation of hydration of the skin, and for improving skin tone
FR3021539A1 (en) COSMETIC AND / OR DERMATOLOGICAL COMPOSITION COMPRISING A VEGETABLE EXTRACT AND A GENE ACTIVATOR
FR2876909A1 (en) Cosmetic and/or pharmaceutical composition, to prevent or treat adipose overloads and cellulitis, comprises a combination of one or more xanthinic bases and chaulmoogra oil and/or its components
FR2888114A1 (en) Cosmetic use of a madecassoside compound in a composition as an agent to prevent/reduce microorganisms on the surface of the skin and/or the mucous membranes
FR3133750A1 (en) New compositions combining hemp derivatives and their use, particularly in cosmetics
FR3110421A1 (en) Narcissus poeticus extract for its cosmetic use
FR2928837A1 (en) USE OF AN EXTRACT OF OLIVE OIL FOR THE CONTROL OF SKIN AGING
FR3099702A1 (en) New cosmetic use of an extract of Epilobium angustifolium
FR3099701A1 (en) New cosmetic use of a combination of oenothein-B and quercetin-3-O-glucuronide
FR3094642A1 (en) New cosmetic use of a glycoprotein extract of Prunus dulcis
FR2992561A1 (en) SOOTHING TOPICAL COMPOSITION BASED ON PAEONIA AND NYMPHAEA EXTRACTS
EP2694028A2 (en) Composition based on chaulmoogra oil and tribulus terrestris for skin pigmentation
FR2986707A1 (en) COMPOSITION COMPRISING APPLE JUICE EXTRACT FOR SKIN COMFORT.

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2008857034

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008857034

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08857034

Country of ref document: EP

Kind code of ref document: A2